| Literature DB >> 31630461 |
Vide Ohlsson Gotby1, Olle Söder2, Louise Frisén3,4, Eva Serlachius3,4, Sven Bölte4,5, Catarina Almqvist1,6, Henrik Larsson1,7, Paul Lichtenstein1, Kristiina Tammimies5,6.
Abstract
Hypogonadotrophic hypogonadism (HH) is a rare disorder that manifests absent puberty and infertility. Genetic syndromes with hypogonadism, such as Klinefelter syndrome, are associated with an increased risk of neurodevelopmental disorders (NDDs). However, it is not clear whether patients with HH or transient delayed puberty in general, have an increased risk of NDDs. We performed a register-based study on a national cohort of 264 patients with HH and 7447 patients diagnosed with delayed puberty that was matched with 2640 and 74 470 controls, respectively. The outcome was defined as having any of the following NDD diagnoses: (i) autism spectrum disorder (ASD); (ii) attention deficit hyperactivity disorder (ADHD); or (iii) intellectual disability (ID). Additional sensitivity analyses were performed to control for different parental and birth variables, as well as diagnosed malformation syndromes and chromosomal anomalies (ie, Down's and Turner syndromes). Patients with HH had increased risk for being diagnosed with ASD (odds ratio [OR] = 5.7; 95% confidence interval [CI] = 2.6-12.6), ADHD (OR = 3.0; 95% CI = 1.8-5.1) and ID (OR = 18.0; 95% CI = 8.9-36.3) compared to controls. Patients with delayed puberty also had a significantly increased risk of being diagnosed with an NDD. These associations remained significant after adjustments. This is the first study to demonstrate a significant association between HH, delayed puberty and NDDs in a population-based cohort. Clinicians should be aware of the overlap between these disorders. Further studies should explore the mechanisms behind these associations.Entities:
Keywords: International Classification of Diseases; attention deficit hyperactivity disorder; autism spectrum disorder; intellectual disability; sex hormones
Year: 2019 PMID: 31630461 DOI: 10.1111/jne.12803
Source DB: PubMed Journal: J Neuroendocrinol ISSN: 0953-8194 Impact factor: 3.627